Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report. 1979

H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan

UI MeSH Term Description Entries
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009946 Organothiophosphorus Compounds Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as CHOLINERGIC AGENTS and as INSECTICIDES. Compounds, Organothiophosphorus
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
January 1983, Cancer chemotherapy and pharmacology,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
June 1987, Lijecnicki vjesnik,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
January 1982, Lijecnicki vjesnik,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
August 1980, Cancer,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
March 1980, The Medical journal of Australia,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
May 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
July 1977, Obstetrics and gynecology,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
September 1984, British journal of obstetrics and gynaecology,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
December 1990, Asia-Oceania journal of obstetrics and gynaecology,
H W Bruckner, and M Pagano, and G Falkson, and R Creech, and J C Arseneau, and J Horton, and H Brodovsky, and T E Davis, and R W Slayton, and E Greenspan
January 1984, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!